Company / Cash & Equivalents
National Healthcare, Corp. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$92.8M
FY2025
5-year range
$76.1M / $147.1M
FY2021-FY2025
Trend
+21.9%
vs FY2024
Sector context
#111 of 148
Health Care
What the data says
National Healthcare, Corp.'s cash & equivalents of $93M is lower than 75% of companies in the Health Care sector (FY2025). Cash & Equivalents returned to growth in FY2025 after 3 years of decline, reaching $93M.
Based on SEC 10-K filings.
$93M in FY2025 with a 5-year CAGR of +13.0%.
Declined from $107M to $93M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -4.8%
- 5-Year CAGR
- +13.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 148This company $92.8M Sector average $1.2B
▼
-92.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +13.0%, indicating consistent growth.
- In FY2025, cash & equivalents increased 21.9% year-over-year.
- Ranks #111 out of 148 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $92.8M | +21.9% |
| FY2024 | $76.1M | -28.9% |
| FY2023 | $107.1M | -0.5% |
| FY2022 | $107.6M | -26.8% |
| FY2021 | $147.1M | +192.2% |
| FY2020 | $50.3M | +0.0% |
| FY2019 | $50.3M | -14.9% |
| FY2018 | $59.1M | +0.0% |
| FY2017 | $59.1M | +124.5% |
| FY2016 | $26.3M | -31.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026